OCULAR THERAPEUTIX, INC Total Liabilities
OCULAR THERAPEUTIX, INC (OCUL) had Total Liabilities of $151.28 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-03
- 2026-06-30: Liabilities $151.28M.
- 2026-03-31: Liabilities $150.96M.
- 2025-12-31: Liabilities $153.75M.
- 2025-09-30: Liabilities $152.65M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $151.28M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $150.96M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $153.75M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $152.65M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $145.42M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $139.99M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $142.59M 10-K · filed 2026-02-05 |
| 2024-09-30 | $138.35M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $139.40M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $130.96M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $160.93M 10-K · filed 2025-03-03 |
| 2023-09-30 | $154.53M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $119.47M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $118.86M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $113.91M 10-K · filed 2024-03-11 |
| 2022-09-30 | $112.35M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $107.27M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $107.83M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $116.89M 10-K · filed 2023-03-06 |
| 2021-09-30 | $130.40M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $150.46M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $159.63M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $185.77M 10-K · filed 2022-02-28 |
| 2020-09-30 | $102.34M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $101.92M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $83.52M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $82.37M 10-K · filed 2021-03-11 |
| 2019-09-30 | $77.41M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $81.48M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $75.84M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $37.17M 10-K · filed 2020-03-12 |
| 2018-09-30 | $24.75M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $24.73M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $27.50M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $29.28M 10-K · filed 2019-03-07 |
| 2017-09-30 | $28.48M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $31.65M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $26.79M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $22.93M 10-K · filed 2018-03-08 |
| 2016-09-30 | $20.05M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $19.45M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $20.26M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $20.72M 10-K · filed 2017-03-10 |
| 2015-09-30 | $20.51M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $20.36M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $19.42M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $19.50M 10-K · filed 2016-03-10 |
| 2014-09-30 | $18.28M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $19.05M 10-Q · filed 2014-08-29 |
| 2013-12-31 | $4.27M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |